borderline significanceP = 0.08
In the subset of patients with a prophylactic mesh, of those who had atrophy of the RAM, 27% developed a PSH compared with 50% of those who did not, with borderline significance ( P = 0.08).
In the subset of patients with a prophylactic mesh, of those who had atrophy of the RAM, 27% developed a PSH compared with 50% of those who did not, with borderline significance ( P = 0.08).